BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei X, Xu A, Shen H, Xie Y. Qianggu capsule for the treatment of primary osteoporosis: evidence from a Chinese patent medicine. BMC Complement Altern Med 2017;17:108. [PMID: 28193278 DOI: 10.1186/s12906-017-1617-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao W, Zhang H, Jiang X, Mehmood K, Iqbal M, Li A, Zhang J, Wang Y, Waqas M, Shen Y, Li J. Effect of Total Flavonoids of Rhizoma drynariae on Tibial Dyschondroplasia by Regulating BMP-2 and Runx2 Expression in Chickens. Front Pharmacol 2018;9:1251. [PMID: 30450047 DOI: 10.3389/fphar.2018.01251] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
2 Zeng H, Zhao X, Wang L, Tang C, Li Z, Xie N, Wang F. Effects of Drynaria Total Flavonoid on the Microstructure of the Mandible in Ovariectomized Rats. Med Sci Monit 2020;26:e926171. [PMID: 33128539 DOI: 10.12659/MSM.926171] [Reference Citation Analysis]
3 Chen G, Guan Y, Ye X, Chen G, Du J, Liu W, Zhao C, Yao N, Xu X. Effects of bushen qianggu method for primary osteoporosis: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e20697. [PMID: 32541521 DOI: 10.1097/MD.0000000000020697] [Reference Citation Analysis]
4 Zhao JJ, Wu ZF, Yu YH, Wang L, Cheng L. Effects of interleukin-7/interleukin-7 receptor on RANKL-mediated osteoclast differentiation and ovariectomy-induced bone loss by regulating c-Fos/c-Jun pathway. J Cell Physiol 2018;233:7182-94. [PMID: 29663382 DOI: 10.1002/jcp.26548] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
5 Dai W, Sun Y, Zhong G. A Network Pharmacology Approach to Estimate the Active Ingredients and Potential Targets of Cuscutae semen in the Treatment of Osteoporosis. Med Sci Monit 2020;26:e920485. [PMID: 32081843 DOI: 10.12659/MSM.920485] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang Y, Jiang J, Shen H, Chai Y, Wei X, Xie Y. Total flavonoids from Rhizoma Drynariae (Gusuibu) for treating osteoporotic fractures: implication in clinical practice. Drug Des Devel Ther 2017;11:1881-90. [PMID: 28694688 DOI: 10.2147/DDDT.S139804] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
7 Zhao J, Zeng L, Wu M, Huang H, Liang G, Yang W, Pan J, Liu J. Efficacy of Chinese patent medicine for primary osteoporosis: A network meta-analysis. Complement Ther Clin Pract 2021;44:101419. [PMID: 34049211 DOI: 10.1016/j.ctcp.2021.101419] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Yao W, Zhang H, Fakhar-E-Alam Kulyar M, Ding Y, Waqas M, Mehmood K, Iqbal M, Du H, Jiang X, Li J. Effect of total flavonoids of Rhizoma Drynariae in thiram induced cytotoxicity of chondrocyte via BMP-2/Runx2 and IHH/PTHrP expressions. Ecotoxicol Environ Saf 2020;206:111194. [PMID: 32866894 DOI: 10.1016/j.ecoenv.2020.111194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang N, Zhao G, Zhang Y, Wang X, Zhao L, Xu P, Shou D. A Network Pharmacology Approach to Determine the Active Components and Potential Targets of Curculigo Orchioides in the Treatment of Osteoporosis. Med Sci Monit 2017;23:5113-22. [PMID: 29074841 DOI: 10.12659/msm.904264] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]